CIK 0001903784 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vogenx, Inc.
Sign in to watch- Ticker
- VOGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863697324
- Phone
- 9196595677
- Business address
- 3901 BARRETT DRIVE, SUITE 300, RALEIGH, NC, 27609
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 10-Q Report Quarterly Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 4 Conversion Director acquired 42,735 shares (conversion)
- 4 Conversion Chief Financial Officer acquired 4,273 shares (conversion)
- 8-K Event Bylaws or fiscal year change
- S-8 Other Securities Offered to Employees in Benefit Plans
- 424B4 Offering Prospectus
Page 1 of 2 · 37 filings